BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $4,794 | -17.5% | 124 | -19.5% | 0.00% | -50.0% |
Q3 2023 | $5,812 | -26.3% | 154 | -11.0% | 0.00% | -33.3% |
Q2 2023 | $7,882 | +5.6% | 173 | -6.0% | 0.00% | 0.0% |
Q1 2023 | $7,463 | -34.3% | 184 | -17.5% | 0.00% | -25.0% |
Q4 2022 | $11,366 | +3.3% | 223 | +7.2% | 0.00% | 0.0% |
Q3 2022 | $11,000 | -8.3% | 208 | +12.4% | 0.00% | 0.0% |
Q2 2022 | $12,000 | -14.3% | 185 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $14,000 | -12.5% | 185 | 0.0% | 0.00% | -20.0% |
Q4 2021 | $16,000 | +6.7% | 185 | 0.0% | 0.01% | 0.0% |
Q3 2021 | $15,000 | -6.2% | 185 | -4.6% | 0.01% | -16.7% |
Q2 2021 | $16,000 | 0.0% | 194 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $16,000 | +6.7% | 194 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $15,000 | +7.1% | 194 | +4.9% | 0.01% | 0.0% |
Q3 2020 | $14,000 | -12.5% | 185 | -1.6% | 0.01% | -14.3% |
Q2 2020 | $16,000 | +6.7% | 188 | +1.6% | 0.01% | -12.5% |
Q1 2020 | $15,000 | 0.0% | 185 | 0.0% | 0.01% | 0.0% |
Q4 2019 | $15,000 | -11.8% | 185 | -8.9% | 0.01% | 0.0% |
Q3 2019 | $17,000 | -65.3% | 203 | -66.3% | 0.01% | -63.6% |
Q2 2019 | $49,000 | -56.2% | 603 | -20.0% | 0.02% | -8.3% |
Q1 2019 | $112,000 | +460.0% | 754 | +148.0% | 0.02% | +166.7% |
Q4 2018 | $20,000 | -13.0% | 304 | 0.0% | 0.01% | 0.0% |
Q3 2018 | $23,000 | +4.5% | 304 | 0.0% | 0.01% | 0.0% |
Q2 2018 | $22,000 | +15.8% | 304 | 0.0% | 0.01% | +12.5% |
Q1 2018 | $19,000 | 0.0% | 304 | 0.0% | 0.01% | 0.0% |
Q4 2017 | $19,000 | 0.0% | 304 | 0.0% | 0.01% | -20.0% |
Q3 2017 | $19,000 | +11.8% | 304 | +7.4% | 0.01% | +11.1% |
Q2 2017 | $17,000 | +13.3% | 283 | -3.7% | 0.01% | +12.5% |
Q1 2017 | $15,000 | +15.4% | 294 | 0.0% | 0.01% | +14.3% |
Q4 2016 | $13,000 | -13.3% | 294 | -8.7% | 0.01% | -22.2% |
Q3 2016 | $15,000 | +7.1% | 322 | -2.1% | 0.01% | +12.5% |
Q2 2016 | $14,000 | 0.0% | 329 | -8.6% | 0.01% | 0.0% |
Q1 2016 | $14,000 | +7.7% | 360 | +0.3% | 0.01% | 0.0% |
Q4 2015 | $13,000 | – | 359 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |